Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Cleaning During Campaign Manufacturing – V 2.0

Posted on By

Elixir Department: SOP for Cleaning During Campaign Manufacturing – V 2.0

Standard Operating Procedure for Cleaning During Campaign Manufacturing in Elixir Production

Department Elixir Department
SOP No. SOP/ELX/177/2025
Supersedes SOP/ELX/177/2022
Page No. Page 1 of 10
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To describe the procedure for intermediate cleaning and control during campaign manufacturing of elixir formulations to prevent build-up of residues and maintain equipment suitability throughout the campaign.

2. Scope

This SOP applies to all equipment, utensils, transfer pipelines, and vessels used continuously or intermittently during multi-batch or campaign manufacturing in the Elixir Department, where the same product is manufactured consecutively.

3. Responsibilities

  • Production Operator:
    • Perform equipment cleaning as per campaign schedule and record in the logbook.
  • Production Supervisor:
    • Monitor cleaning frequency and ensure compliance with limits of batch campaign run.
  • QA Officer:
    • Verify visual cleanliness at defined intervals and after final batch.
    • Approve continuation of campaign or recommend full cleaning.
See also  Elixir Department: SOP for Documentation in Manufacturing Logbooks - V 2.0

4. Accountability

The Production Head is accountable for maintaining batch-to-batch cleaning requirements within campaign runs. The QA Head is responsible for risk-based verification and batch release continuation.

5.

Procedure

5.1 Campaign Justification and Limits

  1. Define the campaign limit (e.g., 3 or 5 batches) in the product-specific master manufacturing record (MMR) or validation protocol.
  2. Campaign runs are permitted only if:
    • The same product is manufactured consecutively
    • No change in formulation or strength
    • Cleaning validation supports extended use

5.2 Cleaning During Campaign

  1. After completion of each batch:
    • Drain and rinse tanks and pipelines with purified water to remove residual traces.
    • Visually inspect for any adhering residues, discoloration, or unusual deposits.
    • Wipe accessible surfaces with lint-free cloth.
  2. Do not use any detergent or solvent unless final batch is completed or residue is excessive.
  3. Maintain a record of intermediate cleaning after each batch (Annexure-1).

5.3 Final Cleaning After Campaign End

  1. Upon completion of last approved batch, perform full cleaning as per validated cleaning SOP (e.g., SOP/ELX/169).
  2. Include detergent washing, rinsing, and swab or rinse sampling for verification.
  3. Only after QA approval, proceed to manufacturing of a different product or strength.

5.4 Hold Time Monitoring

  1. If the equipment is idle for more than the validated hold time during the campaign, perform at least partial cleaning (e.g., hot water rinse).
  2. Document the downtime and any cleaning activity in the Hold Time Log.

5.5 Documentation

  1. Record batch number, date, equipment ID, and cleaning status after each batch.
  2. QA to review cleaning log and provide clearance for continuation or changeover.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • MMR: Master Manufacturing Record

7. Documents

  1. Campaign Cleaning Logbook (Annexure-1)
  2. Cleaning Validation Protocol
  3. Hold Time Record

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
  • WHO TRS 986 – GMP Annex: Cleaning Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Campaign Cleaning Logbook

Date Batch No. Equipment ID Visual Check Done By Cleaning Activity Performed QA Verification Remarks
11/04/2025 ELX-20250411-03 MXR-ELX-08 Rajesh Kumar Water Rinse + Wipe Sunita Reddy Approved for next batch

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New Procedure QA Head
11/04/2025 2.0 Added hold-time monitoring and clarified cleaning limits Validation Update QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events
Next Post: Analytical Method Development: SOP for Impurity Analysis in Nasal Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version